" class="no-js "lang="en-US"> Jean-Christophe Hyvert - Medtech Alert
Wednesday, December 11, 2024
Jean-Christophe Hyvert

Jean-Christophe Hyvert

About Jean-Christophe Hyvert

Jean-Christophe Hyvert joined Lonza in 2017. In his previous role as Chief Commercial Officer, Lonza Pharma Biotech & Nutrition (LPBN), his business expertise and strong understanding of the segment’s financial structure drove LPBN’s strategic approach to commercial development and growth. JeanChristophe originally qualified as a physicist and worked in operations, before moving into a financial role. His experience in operations and finance have provided him with a broad knowledge of both the science and the business sides of Lonza and its divisions.

Related Story

MilliporeSigma Announces Acquisition of MAST® Platform from Lonza, a Leading Automated Bioreactor Sampling System to Advance BioProcessing Capabilities

April 6 2022

MilliporeSigma, the U.S. and Canada life science business of Merck KGaA, Darmstadt, Germany a leading science and technology company, […]